Brand Name: MiniMed Flex Product Name: MiniMed Flex Insulin Pump Model/Catalog Numbers: MMT-8062; MMT-8072 Product Description: The MiniMed Flex pump is an alternate controller enabled (ACE) pump intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. It can reliably and securely communicate with compatible digitally connected devices, including an integrated continuous glucose monitor (iCGM), interoperable Medtronic continuous glucose monitor (CGM), and interoperable automated glycemic controller (iAGC). The pump is intended to be used in conjunction with compatible, digitally connected medical devices for the purpose of drug delivery. The primary user interface and primary display for the MiniMed Flex pump is the MiniMed app, also the user interface for the compatible MiniMed iAGCs, which runs on a compatible iOS or Android device.
原資料は米国FDAの発表(英語)です。商品名・理由は原文のまま表記します。
Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues: inoperable pump at setup, lack of protection for moisture exposure, slow battery charging, disconnection issues with other system components (i.e., continuous glucose monitoring sensor or MiniMed mobile app), reduced ability to detect occlusion events, compromised audio for pump alarms/alerts, and/or inaccurate insulin delivery.
| 製造・販売社 | Medtronic MiniMed, Inc. |
|---|---|
| リコール理由 | Some MiniMed Flex insulin pumps were released with missing (i.e., devices with no result or abort test results are presumed to have failed) or failed verification test results in one or more of 9 functional tests. The unverified/failed pumps released to users potentially have one or more of the following issues: inoperable pump at setup, lack of protection for moisture exposure, slow battery charging, disconnection issues with other system components (i.e., continuous glucose monitoring sensor or MiniMed mobile app), reduced ability to detect occlusion events, compromised audio for pump alarms/alerts, and/or inaccurate insulin delivery. |
| リスク等級 | Class II (Class II · 中) |
| 進行状況 | Ongoing |
| 報告日 | 2026年10月14日 |
| リコール開始日 | 2026年8月20日 |
| 地域 | CA, United States |
| 流通範囲 | U.S. Nationwide distribution in the states of AR, AZ, CO, FL, KS, KY, LA, MI, MN, NJ, NY, OH, PA, SD, TN, TX, and WV. |
| 数量 | 25 |
| コード/ロット | MMT-8072 Lot Code: Serial numbers: FB00015839, FB00016511, FB00014455, FB00011553, FB00015700, FB00011357, FB00019307, FB00014766, FB00014822, FB00015828, FB00018580, FB00010465, FB00014472, FB000157… |
| 区分 | Voluntary: Firm initiated |
| リコール番号 | Z-0088-2027 |
公式出典
U.S. FDA — Recalls, Market Withdrawals & Safety Alerts fda.gov ↗リコール番号でFDA公式サイトから再確認できます。 (リコール番号: Z-0088-2027)
openFDA (U.S. Food & Drug Administration) — food/drug/device enforcement · CC0 1.0 (public domain)
関連情報をさらに探す
上のリンクはリコール番号・商品名で外部検索を開くものであり、検索結果の内容は各サイトの責任です。
このページは米国FDAのデータを整理した生活情報であり、医療アドバイスではありません。正確な内容はFDA公式発表と製造社の案内でご確認ください。